315 related articles for article (PubMed ID: 31005138)
1. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
2. Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients.
Wirk B; Wingard JR
Mycopathologia; 2009 Dec; 168(6):299-311. PubMed ID: 19247798
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions.
Lionakis MS; Lewis RE; Kontoyiannis DP
Clin Infect Dis; 2018 Oct; 67(10):1621-1630. PubMed ID: 29860307
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations.
Pagano L; Busca A; Candoni A; Cattaneo C; Cesaro S; Fanci R; Nadali G; Potenza L; Russo D; Tumbarello M; Nosari A; Aversa F; ;
Blood Rev; 2017 Mar; 31(2):17-29. PubMed ID: 27682882
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Prophylaxis and Preemptive Approaches for the Prevention of Infections in the Stem Cell Transplant Recipient, with Analogies to the Hematologic Malignancy Patient.
Neofytos D
Infect Dis Clin North Am; 2019 Jun; 33(2):361-380. PubMed ID: 31005133
[TBL] [Abstract][Full Text] [Related]
6. Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.
Michallet M; Ito JI
J Clin Oncol; 2009 Jul; 27(20):3398-409. PubMed ID: 19487382
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients.
Norkin M; Wingard JR
J Natl Compr Canc Netw; 2013 Aug; 11(8):941-9. PubMed ID: 23946173
[TBL] [Abstract][Full Text] [Related]
8. Approaches to the early treatment of invasive fungal infection.
Ito JI; Kriengkauykiat J; Dadwal SS; Arfons LM; Lazarus HM
Leuk Lymphoma; 2010 Sep; 51(9):1623-31. PubMed ID: 20629521
[TBL] [Abstract][Full Text] [Related]
9. Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.
Young AY; Leiva Juarez MM; Evans SE
Clin Chest Med; 2017 Sep; 38(3):479-491. PubMed ID: 28797490
[TBL] [Abstract][Full Text] [Related]
10. Fungal Pneumonia in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation.
Pergam SA
Clin Chest Med; 2017 Jun; 38(2):279-294. PubMed ID: 28477639
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients.
Khatri AM; Natori Y; Anderson A; Jabr R; Shah SA; Natori A; Chandhok NS; Komanduri K; Morris MI; Camargo JF; Raja M
Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14162. PubMed ID: 37794708
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Invasive Candidiasis in Patients with Hematologic Malignancy on Antifungal Prophylaxis.
McCort ME; Tsai H
Mycopathologia; 2023 Dec; 188(6):885-892. PubMed ID: 37314582
[TBL] [Abstract][Full Text] [Related]
13. [Invasive fungal infection management in patients with hematological malignancies].
Kanda Y
Rinsho Ketsueki; 2022; 63(9):1270-1278. PubMed ID: 36198553
[TBL] [Abstract][Full Text] [Related]
14. [Invasive yeast infections in neutropenic patients].
Ruiz Camps I; Jarque I
Rev Iberoam Micol; 2016; 33(3):170-5. PubMed ID: 27395023
[TBL] [Abstract][Full Text] [Related]
15. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
Ziakas PD; Kourbeti IS; Mylonakis E
Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
[TBL] [Abstract][Full Text] [Related]
16. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.
Mariette C; Tavernier E; Hocquet D; Huynh A; Isnard F; Legrand F; Lhéritier V; Raffoux E; Dombret H; Ifrah N; Cahn JY; Thiébaut A
Leuk Lymphoma; 2017 Mar; 58(3):586-593. PubMed ID: 27397551
[TBL] [Abstract][Full Text] [Related]
18. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates.
Tunçcan OG; Yegin ZA; Ozkurt ZN; Erbaş G; Akı SZ; Senol E; Yağcı M; Sucak G
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e104-7. PubMed ID: 20307998
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.
Douglas AP; Slavin MA
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1165-1177. PubMed ID: 27710140
[TBL] [Abstract][Full Text] [Related]
20. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation.
Criscuolo M; Fracchiolla N; Farina F; Verga L; Pagano L; Busca A
Expert Rev Hematol; 2023; 16(12):963-980. PubMed ID: 38044878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
